Diagnostic Value of HS-CRP in Stable Angina.

Sponsor
Shiraz University of Medical Sciences (Other)
Overall Status
Completed
CT.gov ID
NCT00719992
Collaborator
(none)
97
1
2
16
6.1

Study Details

Study Description

Brief Summary

The aim of this study was to assess the amount of additive value of HS-CRP levels to a positive exercise tolerance test (ETT) in predicting coronary artery disease (CAD) using coronary angiography as the gold standard. The investigators concluded that HS-CRP can be used as a single predictor of coronary vessel involvement in patients with stable angina and positive ETT.

Condition or Disease Intervention/Treatment Phase
  • Procedure: coronary angiography
N/A

Detailed Description

the investigators included 97 patients with positive ETT and stable angina and saw that Hs-CRP is the only predictor of severity of CAD as compared with coronary angiography in stable angina patients.

Study Design

Study Type:
Interventional
Actual Enrollment :
97 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Diagnostic
Official Title:
Diagnostic Value of HS-CRP in Stable Angina Patients With Positive Exercise Test as Compared With Coronary Angiography.
Study Start Date :
Apr 1, 2006
Actual Primary Completion Date :
Aug 1, 2007
Actual Study Completion Date :
Aug 1, 2007

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

positive ETT, High HS-CRP

Procedure: coronary angiography
effect of level of HS-CRP

Active Comparator: 2

positive ETT, Low HS-CRP

Procedure: coronary angiography
effect of level of HS-CRP

Outcome Measures

Primary Outcome Measures

  1. significant coronary lesion []

Secondary Outcome Measures

  1. severity of CAD []

Eligibility Criteria

Criteria

Ages Eligible for Study:
43 Years to 64 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Stable angina

  • Positive ETT

Exclusion Criteria:
  • Unability to perform ETT

  • Contraindications for ETT and angiography study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cardiology Ward Shiraz University of Medical Sciences Shiraz Fars Iran, Islamic Republic of 51318

Sponsors and Collaborators

  • Shiraz University of Medical Sciences

Investigators

  • Study Director: javad kojuri, M.D., Shiraz University of Medical Sciences

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00719992
Other Study ID Numbers:
  • 4543
First Posted:
Jul 22, 2008
Last Update Posted:
Jul 22, 2008
Last Verified:
Jul 1, 2008
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 22, 2008